January 20, 2017 7:58 PM ET


Company Overview of Amulet Pharmaceuticals, Inc.

Company Overview

Amulet Pharmaceuticals, Inc., a biotechnology company, develops nitric oxide based technologies for safety of cardiovascular stents, medical devices, and drugs. Its nitric oxide technology and products are used in coronary and peripheral vascular drug eluting stents, implantable medical devices, wounds, diabetes therapeutics, pain therapeutics, glaucoma, and self-disinfecting contact lenses and cases. The company was founded in 2001 and is headquartered in Rockville, Maryland.

9430 Key West Avenue

Suite 120

Rockville, MD 20850

United States

Founded in 2001





Key Executives for Amulet Pharmaceuticals, Inc.

Chairman and Chief Executive Officer
Age: 57
Founder, Chief Scientific Officer, Vice President of Pharmacology and Director
Chief Financial Officer, Secretary and Treasurer
Chief Operating Officer
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Amulet Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.